DiscoverThe Lancet Gastroenterology & Hepatology in conversation withMads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

Update: 2024-03-12
Share

Description

Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

The Lancet Group